Latest AI and machine learning research in other cancers for healthcare professionals.
BACKGROUND: Lung cancer, especially small-cell lung cancer (SCLC), is a widespread and deadly diseas...
Brain and central nervous system (CNS) malignancies represent a substantial burden on healthcare sys...
Disorders of the central nervous system (CNS), neurological disorders, neurodegenerative disorders, ...
The immunosuppressive tumor microenvironment (TME) and intrinsic heterogeneity of ovarian cancer (OC...
OBJECTIVE: Accurate imaging-based differentiation of benign and malignant parotid tumors is essentia...
Chronic obstructive pulmonary disease (COPD) is a leading cause of death with few effective therapie...
The study of the impact of physical forces and on cells has emerged as a fertile field of investigat...
BACKGROUND: Lung adenocarcinoma (LUAD) is a predominant contributor to cancer‑related mortality glob...
BACKGROUND: Pancreatic cancer requires nuanced, multidisciplinary treatment planning typically condu...
Risk stratification across the three main clinical subsets of malignant peripheral nerve sheath tumo...
Programmed death-ligand 1 (PD-L1) plays a central role in immune regulation in esophageal squamous c...
BACKGROUND AND OBJECTIVES: Stereotactic body radiotherapy (SBRT) has emerged as an effective treatme...
BACKGROUND: Early prediction of lymph node metastasis (LNM) after neoadjuvant chemoradiotherapy (nCR...
BACKGROUND: Histological typing of carcinomas is crucial considering the varying progression, progno...
Transarterial chemoembolization (TACE) is increasingly used in patients with hepatocellular carcinom...
BACKGROUND: Accurate preoperative differentiation between parathyroid adenoma (PA) and atypical para...
BACKGROUND: Skin cancer is one of the most prevalent cancers globally, with early detection critical...
BACKGROUND: Breast phyllodes tumours (PT) are rare biphasic neoplasms consisting of epithelial and s...
BACKGROUND: International guidelines recommend 5FU/LV, Nal-IRI + 5FU/LV, FOLFIRI, FOLFOX, or (m)FOLF...
177Lu-PSMA-targeted radioligand therapy (TRT) represents a major advance in managing metastatic cast...
Antibody-drug conjugates (ADCs) are a leading area of targeted cancer therapeutics, typically combin...